A new website highlighting developments in HIV pharmacogenomics has been launched, in a collaboration between pharmacology groups at the University of Liverpool, Vanderbilt University in the United States and the University of Lausanne in Switzerland.
Analysis of the interaction between genes and drugs, known as pharmacogenomics, is an accelerating field of research, and the website’s editors believe that, over the coming years, increased knowledge in the field of HIV pharmacogenomics will drive clinical management towards the goal of truly individualised therapy for all patients.
The site includes a list of recent publications with links to PubMed abstracts, and will also include a library of information on HIV pharmacogenomics.
The site is edited by Professor David Back (Liverpool), Dr Richard Kim (Vanderbilt); Dr Amalio Telenti (Lausanne) and Catia Marzolini PhD (Vanderbilt).